93438-65-4,Conantokin G, Polypeptide Customization Services

Dirction：Conantokin G, CAS 93438‑65‑4, is a 17‑amino‑acid synthetic conopeptide. It functions as a selective GluN2B‑subunit NMDA receptor antagonist with neuroprotective effects. HPLC purity ≥98%, supplied as solid powder. Suitable for neuroscience in‑vitro research. Store at ‑20℃, avoid repeated freeze‑thaw cycles. COA and MS test reports are available upon request.

Oinarrizko informazioa:

Marka: Gutuo

itxura:zuriahautsa

biltegiratze: itzaldura, freskoaeta lehorra,zigilatutako kontserbazio garbitasuna: ≥% 99 helburu nagusia: polipeptidoen ikerketa erabilera

Ezarpenaestandar: enpresa estandarra

mg/g/kg (bezeroen eskakizunen arabera)

Salmenta-esparrua: Globala

Peptidoen ohiko galderak:

1. How to judge the peptide synthesis quality is qualified?

each polypeptide will be attached with: - HPLC chromatogram (purity detection) - MS chromatogram (molecular weight verification) After the customer receives it, it can be verified again according to the experimental requirements, and it can be retested and confirmed if necessary.

2. What modifications are supported? Does the modification affect the cycle?

supporting modifications include but are not limited to: -fluorescent labeling (FITC, Cy5, etc.) -cyclization, phosphorylation, fatty acid -biotinylation, C- terminal amidation, N-terminal acetylation and other complex modifications will appropriately extend the synthesis cycle, generally 7-12 working days, and it is recommended to evaluate in advance.